Hims & Hers Health Inc [HIMS] stock is trading at $35.46, saw in change for the day. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HIMS shares have gain 7.32% over the last week, with a monthly amount drifted -9.54%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $48. On June 23, 2025, downgrade downgraded it’s rating to Hold. Needham reiterated its Buy rating and increased its price target to $65 on June 04, 2025. TD Cowen downgraded its rating to a Hold but $30 remained the price target by the analyst firm on April 29, 2025. Morgan Stanley downgraded its rating to Equal-Weight for this stock on February 18, 2025, and upped its price target to $60. In a note dated January 10, 2025, Citigroup downgraded an Sell rating on this stock and boosted its target price from $24 to $25.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $23.97 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $42.83 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $35.46 at the most recent close of the market. An investor can expect a potential return of 20.78% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 2.21B for the trailing twelve months, which represents a growth of 49.16%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.25 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.78 points at the first support level, and at 34.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 36.29, and for the 2nd resistance point, it is at 37.13.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 1.88. Further, the Quick Ratio stands at 1.64, while the Cash Ratio is 0.77. Considering the valuation of this stock, the price to sales ratio is 3.65, the price to book ratio is 13.89 and price to earnings (TTM) ratio is 65.56.
Transactions by insiders
Recent insider trading involved Okupe Oluyemi, Chief Financial Officer, that happened on Jan 05 ’26 when 9070.0 shares were sold. Chief Financial Officer, Okupe Oluyemi completed a deal on Dec 22 ’25 to sell 23090.0 shares. Meanwhile, Officer Oluyemi Okupe bought 32160.0 shares on Dec 22 ’25.
